These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 15313673)
1. Promoting hepatic growth factor in the treatment of heavy type hepatitis and severe chronic hepatitis: a multicenter clinical study. Xu JH; Yu YY; Si CW; Zeng Z; Wang QH; Luo DD; Zhou YX; Zeng MD; Qiao GY; Yao JL; Lu WL Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):381-5. PubMed ID: 15313673 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for chronic severe hepatitis and construction of a prognostic model. Li Q; Yuan GY; Tang KC; Liu GW; Wang R; Cao WK Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):40-4. PubMed ID: 18234637 [TBL] [Abstract][Full Text] [Related]
3. [Case-controlled study of entecavir treatment for chronic severe hepatitis B]. Xiao GM; He KY; Jia WD; Lei CL; Yang Z Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):56-8. PubMed ID: 19799020 [TBL] [Abstract][Full Text] [Related]
4. [Observation on hybrid bioartificial liver support systems in treating chronic severe hepatitis: a study of 60 cases]. Luo HT; Liu QM; Tan JJ; Ye YN; Zhang PH; Luo ZD; Long H Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):205-9. PubMed ID: 16556417 [TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B. Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536 [TBL] [Abstract][Full Text] [Related]
6. A preliminary study on the activation of superoxide dismutase by Tiopronin in patients with chronic hepatitis B. Chen C; Tan Z; Qiu S Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):355-7. PubMed ID: 11471025 [TBL] [Abstract][Full Text] [Related]
7. [Single factor study of prognosis from 520 cases with chronic severe hepatitis]. Zou Z; Chen J; Xin S; Xing H; Li B; Li J; Shen H; Liu Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):246-8. PubMed ID: 12665931 [TBL] [Abstract][Full Text] [Related]
8. [A clinical study of N-acetylcysteine treatment in chronic hepatitis B patients]. Wang N; Shi XF; Guo SH; Zhang DZ; Ren H Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):487-9. PubMed ID: 18647523 [TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of therapeutic effects of "Cooling the blood and invigorating blood circulation" method on hepatitis hyperbilirubinemia]. Li YZ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):73-4. PubMed ID: 16642224 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of non-invasive indices for liver histology in patients with chronic hepatitis B]. Chen YP; Zhu YF; Feng XR; Peng J; Hou JL Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1181-3. PubMed ID: 15485795 [TBL] [Abstract][Full Text] [Related]
11. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors. Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464 [TBL] [Abstract][Full Text] [Related]
12. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study. Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058 [TBL] [Abstract][Full Text] [Related]
13. [Serum level of HMGB1 in patients with hepatitis B and its clinical significance]. Liu HB; Fan XG; Huang JJ; Li N; Peng JP; Li SL; Wang H Zhonghua Gan Zang Bing Za Zhi; 2007 Nov; 15(11):812-5. PubMed ID: 18073062 [TBL] [Abstract][Full Text] [Related]
14. [Pathologic grading and clinical features of chronic hepatitis B]. Ma H; Lang Z; Jin R; Huang C; Jin R Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):52-4. PubMed ID: 11856505 [TBL] [Abstract][Full Text] [Related]
15. Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B. Yang SS; Cheng KS; Lai YC; Wu CH; Chen TK; Lee CL; Chen DS J Gastroenterol; 2002; 37(8):626-32. PubMed ID: 12203078 [TBL] [Abstract][Full Text] [Related]
16. [A multi-center clinical study of N-acetylcysteine on chronic hepatitis B]. Shi XF; Guo SH; Wu G; Mao Q; Yu YS; Wang JK; Zhang L; Wang ZY; Zhang XQ; Zhang QH; Zhao YR; Zeng WQ Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):20-3. PubMed ID: 15670485 [TBL] [Abstract][Full Text] [Related]
17. [The efficacy of two type of membrane plasma separator on the treatment of patients with chronic severe hepatitis B]. Zhang DZ; Zhao YR; Zhang QH; Wang ZY; Qin B; He H; Zhou Z; Guo SH Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):208-9. PubMed ID: 15099467 [TBL] [Abstract][Full Text] [Related]
19. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial]. Yin SS; Wang BE; Wang TL; Jia JD; Qian LX Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205 [TBL] [Abstract][Full Text] [Related]
20. Short-term entecavir therapy of chronic severe hepatitis B. Chen J; Han JH; Liu C; Yu RH; Li FZ; Li QF; Gong GZ Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):261-6. PubMed ID: 19502165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]